Want to join the conversation?
In 2Q16, in $SHLM's EMEA segment, reported net sales were $290.3MM, down 7.9% from 2Q15. The USCAN segment saw a revenue increase of 28% to $170.8MM. In Latin America, segment revenue was down 7%. In APAC, net sales were $45.1MM, down 4.8% from 2Q15. In Engineered Composites, net sales were $47.4MM, down 8.6%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?